• <code id="ossuk"></code>
    • <li id="ossuk"></li>
    • <rt id="ossuk"></rt>
    • <rt id="ossuk"><tr id="ossuk"></tr></rt>
      <abbr id="ossuk"></abbr>
      <rt id="ossuk"><acronym id="ossuk"></acronym></rt>
      產品中心您現在的位置:首頁 > 產品展示 > 抗體 > 內參抗體 > InVivoMab anti-human PD-1 (CD279)

      InVivoMab anti-human PD-1 (CD279)

      更新時間:2022-01-27

      簡要描述:

      The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of……

      型號:廠商性質:代理商瀏覽量:930

      The J116 monoclonal antibody reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1's structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease in mice as PD-1 knockout animals show dilated cardiomyopathy, splenomegaly, and loss of peripheral tolerance. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In mouse models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Binding of the J116 antibody is reported to inhibit PD-1 signal transduction, however, it is not reported to block PD-L1 binding.


      產品名稱:InVivoMab anti-human PD-1 (CD279)

      反應種屬:human

      宿主來源:mouse

      實驗應用:in vitro PD-1 neutralization, in vivo PD-1 blockade in humanized mice

      同種型:IgG1, κ

      克隆性:Monoclonal

      克隆號:J116

      產品濃度:Lot specific,typically between 4-11 mg/ml

      保存溫度:Undiluted at 4°C in the dark

      運輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

      預期分子量:150 kDa

      產品形式:液體

      有效期:One year from the date of receipt if stored as recommended

      產地:美國



      如需購買或咨詢Bioxcell公司的產品,請聯系Bioxcell*代理商欣博盛生物


      留言框

      • 產品:

      • 您的單位:

      • 您的姓名:

      • 聯系電話:

      • 常用郵箱:

      • 省份:

      • 詳細地址:

      • 補充說明:

      • 驗證碼:

        請輸入計算結果(填寫阿拉伯數字),如:三加四=7
      国产热re99久久6国产精品| 国内精品久久久久久久coent| 99久久99久久精品免费看蜜桃| 久久66热人妻偷产精品9| 2021国产精品久久久久| 9i9精品国产免费久久| 亚洲精品无码久久久久牙蜜区| 国产a级一级久久毛片| 久久av无码专区亚洲av桃花岛| 色青青草原桃花久久综合| 久久精品国产一区二区三区肥胖| 久久久精品人妻一区二区三区四| 国内精品久久久久影院网站 | 久久久精品国产免大香伊| 国内精品久久久久久影院| 青草国产精品久久久久久| 久久精品国产亚洲AV电影网| 国产日韩久久久精品影院首页| 国内精品久久久久| 久久伊人精品一区二区三区| 亚洲国产精品无码久久久蜜芽| 久久久国产打桩机| 久久久久久久99精品免费| 香港aa三级久久三级老师| 91久久香蕉国产线看观看软件| 久久精品免视看国产陈冠希| 中文字幕久久亚洲一区| 久久亚洲精品无码aⅴ大香| 亚洲va中文字幕无码久久| 伊人久久大香线蕉综合爱婷婷| 一本一本久久a久久精品综合麻豆| 久久午夜夜伦鲁鲁片免费无码| 国产欧美另类久久久精品图片| 亚洲午夜久久久精品电影院| 久久久av波多野一区二区| 无码人妻久久一区二区三区| 精品极品三级久久久久| 久久精品一品道久久精品9| 亚洲精品乱码久久久久久中文字幕 | 精品香蕉久久久午夜福利| 亚洲欧洲国产综合AV无码久久|